in this issue

From the Editor

diaTribe #20 – a special reunion issue and a time for reflection.

Fingersticks

With too much hard work, we all start to feel a little burnt out – the pancreas is no exception!

featured article

Two new exciting JDRF partnerships highlight the changing landscape in diabetes.

Logbook

Is diabetes a disability? James Hirsch’s son, Garrett, wants to know.

Test Drive

Carol King recounts her “Victoza Journey,” detailing her experiences with the new type 2 diabetes drug.

diaTribe Dialogue

diaTribe catches up with Dr. Richard Bergenstal, president of the American Diabetes Association.

Calibra’s new insulin patch-pen the Finesse, the Insulet OmniPod goes abroad, Novo Nordisk’ child-friendly NovoPen Echo, Novo Nordisk’s launch of its once-daily GLP-1 Victoza in the US, First-Lady Michelle Obama’s initiative to reduce childhood obesity, the JDRF’s Adult Type 1 ToolKit, and more.

thinking like a pancreas

A thorough review and “how-to” on the drug Symlin (Amylin’s pramlintide).

Learning Curve

Metformin moonlights as a preventative cancer treatment.

What We're Reading

Dr. Roman Hovorka’s exciting work on the artificial pancreas.

Conference Pearls

Pass the streusel: the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria.

Trial Watch

Canagliflozin (SGLT2 inhibitor for type 2), teplizumab (CD3 inhibitor for type 1), and bariatric surgery (for type 2).

SUM Musings

Kerri Morrone Sparling takes the next step: her path to CGM.

in this issue

Issue 20